IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
Laurus Labs IPO is a Book Building listing on BSE,NSE exchange, with an ipo size of ₹ 1331.80 Cr. The company is based in Visakhapatnam and caters to Pharmaceutical sector. Citigroup Global Markets India , Jefferies India , Kotak Mahindra Capital Company , SBI Capital Markets are the merchant bankers of Laurus Labs IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 19th August 2016.
Laurus Labs IPO posted revenues of ₹ 1,855.08 Cr. and PAT of ₹ 164.02 Cr. in FY17 on annualised basis.
Revenue:
₹ 1,855.08 Cr.
EBITDA Margin:
23.03
% 
Net Worth: ₹ 928.93 Cr.
Market Capitalisation:
[●]
P/E:
30.00 times
P/BV: [●]
EV/EBITDA: 1.95 times
Financial results of Laurus Labs IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | Sep-16 | FY16 | FY15 | FY14 | |
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 2580.53 | 2308.34 | 1892.54 | 1273.05 | |
| Net Worth | 928.93 | 851.81 | 722.10 | 758.41 | |
| Total Debt | 845.42 | 928.83 | 735.30 | 500.35 | |
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
927.54
1,855.08 |
1780.83 | 1326.31 | 1159.71 | |
EBITDA
EBITDA on annualised basis |
213.63
427.26 |
389.60 | 239.40 | 217.68 | |
PAT
PAT on annualised basis |
82.01
164.02 |
143.56 | 73.51 | 97.21 | |
Laurus Labs IPO PAT Margin is 8.84 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows Laurus Labs IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | Sep-16 | FY16 | FY15 | FY14 |
|---|---|---|---|---|
| EBITDA Margin (%) | 23.03 | 21.88 | 18.05 | 18.77 |
| PAT Margin (%) | 8.84 | 8.06 | 5.54 | 8.38 |
| EPS (₹) | 7.59 | 13.48 | 7.71 | 11.98 |
| ROE (%) | 8.83 | 16.85 | 10.18 | 12.82 |
| ROCE (%) | [●] | [●] | [●] | [●] |
| ROA (%) | 3.18 | 6.22 | 3.88 | 7.64 |
| Debt to Equity | 0.91 | 1.09 | 1.02 | 0.66 |
The market Capitalisation of Laurus Labs IPO is ₹ 0.00 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Laurus Labs IPO prospectus highlights an Return on Equity (ROE) of 8.83 % , Return on Assets (ROA) of 3.18 %, and an EBITDA Margin of 23.03 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Laurus Labs IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Laurus Labs IPO is ₹ 0.00 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Laurus Labs IPO has a Price-to-Earnings (PE) ratio of 30.00 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Laurus Labs IPO reported revenue of ₹ 1883.58 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Laurus Labs IPO provide insights into sales growth, market demand, and business scalability.
Laurus Labs recorded an EBITDA of ₹ 427.26 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Laurus Labs Profit After Tax (PAT) is ₹ 164.02 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 1,855.08 Cr.
EBITDA Margin:
23.03
%
Net Worth: ₹ 928.93 Cr.
Market Capitalisation:
[●]
P/E:
30.00 times
P/BV: [●]
EV/EBITDA:
[●]
Laurus Labs operates in Pharmaceutical and Pharmaceutical. The Issue is listed on BSE,NSE in Dec, 2016. Laurus Labs IPO size was 1331.80 with Issue price of 428.00 .
Merchant Banker(s) of Laurus Labs IPO: Citigroup Global Markets India Private Limited , Jefferies India Private Limited , Kotak Mahindra Capital Company Limited , SBI Capital Markets Limited
Laurus Labs IPO subscription was 4.53 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Laurus Labs IPO listed at a listing price of 480.50 against the offer price of 428.00.
The current market price of Laurus Labs is 827.00.
Why Us?
